H. S. Walter, S. A. Rule, M. J. S. Dyer, L. Karlin, C. Jones, et al.. A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.
Blood, American Society of Hematology, 2016, 127 (4), pp.411-419.
⟨10.1182/blood-2015-08-664086⟩.
⟨hal-01796198⟩